JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$2.3B |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$1.64B |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.55B |
| 4 |
iShares MBS ETF
MBB
|
+$1.29B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$693M |
| 2 |
CVS Health
CVS
|
+$676M |
| 3 |
Johnson & Johnson
JNJ
|
+$669M |
| 4 |
Mondelez International
MDLZ
|
+$593M |
| 5 |
UnitedHealth
UNH
|
+$572M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.25% |
| 2 | Technology | 12.49% |
| 3 | Financials | 12.17% |
| 4 | Healthcare | 9.9% |
| 5 | Consumer Discretionary | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2376
Ingersoll Rand
IR
$30.7B
| $5.77M | ﹤0.01% |
207,383
+172,787
| +499% | +$4.35M |
2017 Q2
7 quarters
|
|
2377
iShares Global Energy ETF
IXC
$3.07B
| $5.76M | ﹤0.01% |
170,938
+30,101
| +21% | +$985K |
2013 Q2
23 quarters
|
|
|
TIF
2378
CALL
DELISTED
Tiffany & Co.
TIF
| $5.73M | ﹤0.01% |
54,300
+29,300
| +117% | +$2.69M |
2018 Q4
1 quarter
|
|
2379
Evogene
EVGN
$6.59M
| $5.72M | ﹤0.01% |
34,448
| – | – |
2016 Q1
12 quarters
|
|
|
CERN
2380
CALL
DELISTED
Cerner Corp
CERN
| $5.72M | ﹤0.01% |
100,000
-10,600
| -10% | -$590K |
2018 Q3
2 quarters
|
|
|
JNPR
2381
PUT
DELISTED
Juniper Networks
JNPR
| $5.7M | ﹤0.01% |
215,500
+25,000
| +13% | +$673K |
2018 Q3
2 quarters
|
|
|
SAGE
2382
PUT
DELISTED
Sage Therapeutics
SAGE
| $5.68M | ﹤0.01% |
35,700
+34,600
| +3,145% | +$5.01M |
2018 Q3
2 quarters
|
|
2383
CALL
Sysco
SYY
$37.1B
| $5.67M | ﹤0.01% |
85,000
+40,000
| +89% | +$2.6M |
2018 Q4
1 quarter
|
|
|
2384
PUT
Sysco
SYY
$37.1B
| $5.67M | ﹤0.01% |
85,000
+40,000
| +89% | +$2.6M |
2018 Q4
1 quarter
|
|
2385
abrdn Physical Gold Shares ETF
SGOL
$6.96B
| $5.66M | ﹤0.01% |
454,750
| – | – |
2013 Q2
23 quarters
|
|
2386
CALL
Expedia Group
EXPE
$31.2B
| $5.65M | ﹤0.01% |
47,500
-36,800
| -44% | -$4.47M |
2017 Q4
5 quarters
|
|
|
AXNX
2387
DELISTED
Axonics, Inc. Common Stock
AXNX
| $5.64M | ﹤0.01% |
235,441
-846
| -0.4% | -$15.3K |
2018 Q4
1 quarter
|
|
2388
Fulton Financial
FULT
$4.27B
| $5.62M | ﹤0.01% |
363,261
-520,400
| -59% | -$8.5M |
2013 Q2
23 quarters
|
|
2389
WisdomTree US LargeCap Dividend Fund
DLN
$6.24B
| $5.62M | ﹤0.01% |
119,298
-14,910
| -11% | -$678K |
2015 Q4
13 quarters
|
|
2390
Tandem Diabetes Care
TNDM
$1.13B
| $5.62M | ﹤0.01% |
88,487
+69,963
| +378% | +$3.68M |
2018 Q1
4 quarters
|
|
|
XYZ
2391
CALL
Block Inc
XYZ
$46B
| $5.62M | ﹤0.01% |
75,000
+25,000
| +50% | +$1.81M |
2018 Q4
1 quarter
|
|
2392
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.7B
| $5.61M | ﹤0.01% |
218,954
+40,986
| +23% | +$962K |
2017 Q1
8 quarters
|
|
|
KNL
2393
DELISTED
Knoll, Inc.
KNL
| $5.61M | ﹤0.01% |
296,908
-63,542
| -18% | -$1.26M |
2013 Q2
23 quarters
|
|
2394
Ironwood Pharmaceuticals
IRWD
$598M
| $5.61M | ﹤0.01% |
494,929
+186,509
| +60% | +$2.08M |
2014 Q3
18 quarters
|
|
2395
Alpha Metallurgical Resources
AMR
$2.25B
| $5.6M | ﹤0.01% |
96,680
+8,344
| +9% | +$511K |
2018 Q4
1 quarter
|
|
2396
Terex
TEX
$6.49B
| $5.59M | ﹤0.01% |
173,891
-122,655
| -41% | -$3.89M |
2013 Q2
23 quarters
|
|
2397
CALL
US Bancorp Series B Preferred Stock
USB.PRH
$731M
| $5.58M | ﹤0.01% |
115,700
+21,200
| +22% | +$409K |
2018 Q2
3 quarters
|
|
|
WP
2398
CALL
DELISTED
Worldpay, Inc.
WP
| $5.57M | ﹤0.01% |
+49,100
| New | +$4.45M |
2019 Q1
0 quarters
|
|
|
PDCE
2399
DELISTED
PDC Energy, Inc.
PDCE
| $5.57M | ﹤0.01% |
136,867
-49,303
| -26% | -$1.8M |
2013 Q2
23 quarters
|
|
|
EPZM
2400
DELISTED
Epizyme, Inc
EPZM
| $5.57M | ﹤0.01% |
449,160
+71,917
| +19% | +$804K |
2014 Q1
20 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2019 Portfolio in Review
As of Q1 2019, JP Morgan Chase held 6,314 positions worth $490B, up 13% from $432B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q1 2019 filing shows 537 new, 2,080 increased, 2,670 reduced and 537 closed positions. Its largest new stake was Lyft: 2,510,596 shares worth $197M. The largest sale was Apple, an estimated $693M.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 26% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q1 2019 buy was Lyft: 2,510,596 shares worth $197M.
- JP Morgan Chase added most to Vanguard Total International Bond ETF in Q1 2019, an estimated $2.3B increase.
- JP Morgan Chase's biggest Q1 2019 reduction was Apple, cutting an estimated $693M.
- JP Morgan Chase fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $164M.
- JP Morgan Chase's ten largest holdings make up 16% of its $490B portfolio in Q1 2019.
- JP Morgan Chase opened 537 new positions and closed 537 in Q1 2019.
- JP Morgan Chase's portfolio value rose 13% quarter-over-quarter to $490B.
Based on JP Morgan Chase's 13F filing for Q1 2019, filed 7 May 2019.